Alvea Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Alvea is a biotechnology research company based in Cambridge, Massachusetts, pursuing a simple, scalable, and shelf-stable COVID-19 vaccine and applying rigorous testing to its candidates. A multidisciplinary team—including physicians, scientists, and logistics experts—works continuously to advance the program. Industry reporting describes Alvea as developing SARS-CoV-2 DNA vaccines with a focus on affordability and broad access, aiming to reduce vaccine inequity and strengthen resilience against future global health threats. The firm was established in February 2022 with the goal of rapidly developing and deploying an Omicron-specific vaccine. Within the biotechnology landscape, Alvea is a smaller organization leveraging cross-disciplinary expertise to address COVID-19 vaccine needs.